Stephen Parker

Stephen Parker

Vermogen: 184 194 $ op 31-08-2026

67 jaar
Health Technology
Finance
Commercial Services

Profiel

Dr. Stephen B. Parker is a Non-Executive Chairman at Biodexa Pharmaceuticals Plc, a Non-Executive Chairman at Drishti Discoveries Ltd., an Executive Chairman at Sareum Holdings Plc and a Partner at Celtic Pharma Management LP.
He is on the Board of Directors at Eternans Ltd., Sp2 Asset Management Ltd., Sareum Ltd. and Sp2 Consulting Ltd. Dr. Parker was previously employed as a Non-Executive Chairman by MGC Pharmaceuticals Ltd., a Chairman by Liverpool Chirochem Ltd., an Independent Non-Executive Director by Silence Therapeutics Plc, a Partner by Beehive Capital LLP, a Non-Executive Chairman by Physiomics Plc, a Principal by Celtic Pharma Holdings Advisors LLP, a Chief Financial Officer by Oxford GlycoSciences Plc, a Chairman by Ah Animal Healthcare Ltd., a Principal by Apax Partners LLP, a Principal by Barings Plc, a Head-Partner Network, Research & Development by Bedford Royalties Ltd., a Non-Executive Director by Gammadelta Therapeutics Ltd., a Consultant by PA Consulting Group Holdings Ltd., a Co-Founder by UK Stem Cell Foundation, and a Principal by Warburg Group Plc.
He also served on the board at Albucasis Ltd., Celtic Pharma Development UK Plc, Celtic Pharma GP Ltd., Houlihan Lokey Advisory Ltd., Novacta Biosystems Ltd., PBB Devices Ltd., Xenova Group Plc and Xenova Ltd. He received his undergraduate degree from the University of East Anglia, an MBA from Bayes Business School and a doctorate degree from the University of Oxford.

Bekende belangen in openbare bedrijven

OndernemingDatumAantal aandelenTotale waardeWaarderingsdatum
26-03-2025 405.045 ( 0,29% ) 184 194 $ 31-08-2026
12-03-2026 0 ( -.--% ) - $ 31-08-2026

Actieve functies van Stephen Parker

BedrijvenFunctieBegin
BIODEXA PHARMACEUTICALS PLC Voorzitter 20-06-2022
SAREUM HOLDINGS PLC Voorzitter 17-05-2016
Sp2 Consulting Ltd.
Directeur/Bestuurslid -
Eternans Ltd.
Directeur/Bestuurslid 01-07-2019
Voorzitter 01-01-2021
Directeur/Bestuurslid -
Sp2 Asset Management Ltd.
Directeur/Bestuurslid 01-09-2018
Private Equity Investor 01-04-2005

Eerdere bekende functies van Stephen Parker

BedrijvenFunctieEinde
ARGENT BIOPHARMA LIMITED Voorzitter 01-12-2023
░░░░░░░ ░░░░░░░░░░░░ ░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░░░░░░ ░░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Ervaring van Stephen Parker in detail bekijken

Opleiding van Stephen Parker

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

63

Eerstegraads connecties

33

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit33

Commercial Services

Miscellaneous

Finance

Health Technology

Finance

Commercial Services

Consumer Services

Commercial Services

Finance

Finance

Health Technology

Finance

Commercial Services

Consumer Services

Finance

Finance

Consumer Services

Miscellaneous

Health Technology

Finance

Health Technology

Retail Trade

Celtic Pharma GP Ltd.

Xenova Ltd.

Commercial Services

Health Technology

Health Technology

Sp2 Consulting Ltd.

Health Technology

Health Technology

Eternans Ltd.

Health Technology

Sp2 Asset Management Ltd.

  1. Beurs
  2. Insiders
  3. Stephen Parker